Ignoring the 28-Day Rule: Its tempting to try and stretch a vial beyond its 28-day limit to save a few dollars
If you dose at 5pm on Monday but 9am on Wednesday, you're preventing your GI tract from adapting to a predictable rhythm

Based on community reports: What users commonly report: Reduced inflammation and redness (24 weeks) Slower lesion progression Improved healing of cracked/bleeding plaques Better response to other treatments when stacked What peptides likely won't do: Completely clear severe psoriasis Replace biologics for moderate-to-severe cases Work immediately (expect 48 week timeline) Protocol Considerations Starting a Peptide Protocol for Psoriasis Get a baseline: Document current lesion coverage (photos, PASI score if available) Start with one peptide: GHK-Cu or BPC-157 alone for 24 weeks Add sequentially: This lets you identify what's helping Track consistently: Weekly photos, symptom diary Sample Stack (Not Medical Advice) Conservative approach: GHK-Cu 1 mg subQ daily (skin repair focus) BPC-157 250 mcg subQ daily (anti-inflammatory) Duration: 8 weeks, then reassess More aggressive approach (for those comfortable with peptides): KLOW blend per dosing guide (covers BPC/TB/GHK) Add KPV 200 mcg if available (NF-B focus) Duration: 812 weeks Complementary Strategies Peptides work best alongside foundational approaches: Diet: Anti-inflammatory diet, reduce processed foods Vitamin D: Optimize levels (psoriasis has strong Vitamin D connection) Omega-3s: High-dose fish oil (24g EPA/DHA) Stress management: Psoriasis flares with cortisol Topicals: Continue prescribed treatments Frequently Asked Questions Q: Can I use peptides while on biologics (Humira, Skyrizi, etc.)

sometimes stronger hair and nails) layered on top of cellular protection (telomere maintenance, restored melatonin, more antioxidant defense)
Antioxidant Properties Research in rats has shown that BPC-157 can neutralize certain oxidative stress markers like nitric oxide and malondialadehyde (MDA) [3]
DNA damage in sperm has been linked to an increase in recurrent pregnancy loss, recurrent implantation failure of embryos, poor embryo development, reduced pregnancy and live birth rates and health complications in children